Pages that link to "Q27675486"
Jump to navigation
Jump to search
The following pages link to Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding (Q27675486):
Displaying 50 items.
- Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence (Q26767362) (← links)
- Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1 (Q26782237) (← links)
- A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine (Q26830360) (← links)
- Computational Refinement and Validation Protocol for Proteins with Large Variable Regions Applied to Model HIV Env Spike in CD4 and 17b Bound State (Q27303608) (← links)
- Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques (Q27318508) (← links)
- Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells (Q27320687) (← links)
- Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection (Q27640572) (← links)
- Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein (Q28534454) (← links)
- Survivors Remorse: antibody-mediated protection against HIV-1. (Q30238730) (← links)
- Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic. (Q30366175) (← links)
- Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition (Q33821896) (← links)
- Epitope target structures of Fc-mediated effector function during HIV-1 acquisition (Q33924272) (← links)
- HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2. (Q34402446) (← links)
- Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication (Q34869927) (← links)
- Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120. (Q34885869) (← links)
- HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques (Q35032794) (← links)
- Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine (Q35058245) (← links)
- Allosteric induction of the CD4-bound conformation of HIV-1 Gp120. (Q35058860) (← links)
- Structure and immune recognition of trimeric pre-fusion HIV-1 Env. (Q35142291) (← links)
- Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection (Q35156935) (← links)
- Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults (Q35415717) (← links)
- Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission (Q35488153) (← links)
- Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells (Q35833324) (← links)
- Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1 (Q35913921) (← links)
- Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells (Q35973601) (← links)
- HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans (Q36252656) (← links)
- Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells (Q36266486) (← links)
- A Bivalent, Chimeric Rabies Virus Expressing Simian Immunodeficiency Virus Envelope Induces Multifunctional Antibody Responses (Q36294739) (← links)
- Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity (Q36736588) (← links)
- Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies (Q36811996) (← links)
- A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies (Q36906910) (← links)
- Development of prophylactic vaccines against HIV-1. (Q37042563) (← links)
- Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition (Q37261545) (← links)
- Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins (Q37363561) (← links)
- Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240 (Q37402557) (← links)
- Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001 (Q37409262) (← links)
- Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses (Q37426168) (← links)
- Antigenic properties of the HIV envelope on virions in solution (Q37547245) (← links)
- Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity (Q37644079) (← links)
- Role of Fc-mediated antibody function in protective immunity against HIV-1. (Q38213061) (← links)
- Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir. (Q38673539) (← links)
- Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. (Q38725490) (← links)
- Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects (Q38727815) (← links)
- Crosslinking of a CD4 Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques (Q38793711) (← links)
- HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies (Q38897259) (← links)
- Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies (Q38998925) (← links)
- Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field (Q39189458) (← links)
- Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity (Q40052007) (← links)
- BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity (Q40279352) (← links)
- Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses (Q40366464) (← links)